Jill C. Fehrenbacher, PhD - Publications

Pharmacology and Toxicology Indiana University School of Medicine, Indianapolis, IN, United States 
pain, neurotrophins, estradiol, estrogen

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Shah FL, Atallah N, Grimard M, Guo C, Zhang C, Fehrenbacher J, Kelley MR, Fishel M. Abstract 4802: Combination therapy in PDAC involving blockade of the APE1/Ref-1 signaling pathway: An investigation into drug synthetic lethality and anti-neuropathy therapeutic approach Cancer Research. 78: 4802-4802. DOI: 10.1158/1538-7445.Am2018-4802  0.32
2017 Fehrenbacher JC, Guo C, Kelley MR, Vasko MR. DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1. Neuroscience. PMID 28965839 DOI: 10.1016/J.Neuroscience.2017.09.039  0.8
2017 Shah F, Logsdon D, Messmann RA, Fehrenbacher JC, Fishel ML, Kelley MR. Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic. Npj Precision Oncology. 1. PMID 28825044 DOI: 10.1038/s41698-017-0023-0  0.32
2017 Kelley MR, Fehrenbacher JC. Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage. Neural Regeneration Research. 12: 72-74. PMID 28250749 DOI: 10.4103/1673-5374.198986  0.32
2016 Malty RH, Hudmon A, Fehrenbacher JC, Vasko MR. Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A. Journal of Neuroinflammation. 13: 181. PMID 27400965 DOI: 10.1186/S12974-016-0645-0  0.8
2016 Duarte DB, Vasko MR, Fehrenbacher JC. Models of Inflammation: Carrageenan Air Pouch. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. 72: 5.6.1-9. PMID 26995549 DOI: 10.1002/0471141755.ph0506s72  0.8
2016 Pittman SK, Gracias NG, Fehrenbacher JC. Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons. Experimental Neurology. PMID 26883566 DOI: 10.1016/J.Expneurol.2016.02.010  0.76
2015 Fehrenbacher JC. Chemotherapy-induced peripheral neuropathy. Progress in Molecular Biology and Translational Science. 131: 471-508. PMID 25744683 DOI: 10.1016/bs.pmbts.2014.12.002  0.76
2015 Fehrenbacher JC, Bingener J, Aho JM, Wasky PR, Locke EE, Schwesinger WH, Van Sickle KR, Hargreaves KM. Men with acute cholecystitis have higher tissue-based cytokine levels than women: A cross-sectional study Chirurgia (Turin). 28: 49-53.  0.76
2014 Chen X, Sun W, Gianaris NG, Riley AM, Cummins TR, Fehrenbacher JC, Obukhov AG. Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel. The Journal of Biological Chemistry. 289: 9600-10. PMID 24569998 DOI: 10.1074/Jbc.M113.536862  0.76
2014 Pittman SK, Gracias NG, Vasko MR, Fehrenbacher JC. Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture. Experimental Neurology. 253: 146-53. PMID 24374060 DOI: 10.1016/J.Expneurol.2013.12.011  0.76
2012 Duarte DB, Vasko MR, Fehrenbacher JC. Models of inflammation: carrageenan air pouch. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit5.6. PMID 22383000 DOI: 10.1002/0471141755.ph0506s56  0.76
2012 Fehrenbacher JC, Vasko MR, Duarte DB. Models of inflammation: Carrageenan- or complete Freund's Adjuvant (CFA)-induced edema and hypersensitivity in the rat. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit5.4. PMID 22382999 DOI: 10.1002/0471141755.ph0504s56  0.76
2011 Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL, Liu N, Xiong W, Ripsch MS, Wang Y, Fehrenbacher JC, Fitz SD, Khanna M, Park CK, Schmutzler BS, et al. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex. Nature Medicine. 17: 822-9. PMID 21642979 DOI: 10.1038/Nm.2345  0.76
2010 Park KA, Fehrenbacher JC, Thompson EL, Duarte DB, Hingtgen CM, Vasko MR. Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons. Neuroscience. 171: 910-23. PMID 20870010 DOI: 10.1016/J.Neuroscience.2010.09.027  0.76
2009 Fehrenbacher JC, Sun XX, Locke EE, Henry MA, Hargreaves KM. Capsaicin-evoked iCGRP release from human dental pulp: a model system for the study of peripheral neuropeptide secretion in normal healthy tissue. Pain. 144: 253-61. PMID 19428185 DOI: 10.1016/j.pain.2009.03.027  0.76
2009 Fehrenbacher JC, Loverme J, Clarke W, Hargreaves KM, Piomelli D, Taylor BK. Rapid pain modulation with nuclear receptor ligands. Brain Research Reviews. 60: 114-24. PMID 19162071 DOI: 10.1016/J.Brainresrev.2008.12.019  0.76
2008 Jeske NA, Diogenes A, Ruparel NB, Fehrenbacher JC, Henry M, Akopian AN, Hargreaves KM. A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain. 138: 604-16. PMID 18381233 DOI: 10.1016/j.pain.2008.02.022  0.76
2006 Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, Hargreaves KM. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain. 125: 114-24. PMID 16781076 DOI: 10.1016/j.pain.2006.05.007  0.76
2006 Zhang YH, Fehrenbacher JC, Vasko MR, Nicol GD. Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons. Journal of Neurophysiology. 96: 1042-52. PMID 16723416 DOI: 10.1152/jn.00120.2006  0.76
2005 Fehrenbacher JC, Burkey TH, Nicol GD, Vasko MR. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain. 113: 113-22. PMID 15621371 DOI: 10.1016/j.pain.2004.09.031  0.76
2003 Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 105: 133-41. PMID 14499429 DOI: 10.1016/S0304-3959(03)00173-8  0.76
Show low-probability matches.